Akero Therapeutics, Inc. (AKRO)

54.65 0.00 (0.00%) USD  |  NASDAQ  |  Dec 12, 16:00
More

Akero Therapeutics EPS Diluted (TTM): -3.749 for Sept. 30, 2025

EPS Diluted (TTM) Chart

View EPS Diluted (TTM) for AKRO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
Pfizer Inc. 1.716
Eli Lilly & Co. 20.22
Bristol Myers Squibb Co. 2.962
Johnson & Johnson 10.36
Adaptive Biotechnologies Corp. -0.5382